EPM News Update
Penn Pharma had a fully contained Bosch GKF HiProtect combination dose capsule filler installed at its new facility in South Wales, UK, to enable the development and manufacture of capsules containing highly potent compounds.
The capsule filler, which has been manufacturing capsules since the launch of Penn’s new facility in September, allows the production of capsules containing highly potent compounds safely at either development or commercial scale. As capsule formulation is often the preferred route of administration during the clinical phase of a development programme, this technology from Bosch ensures Penn is able to support this particular customer need.
Mark Dean-Netscher, Penn Pharma’s COO, said: “The capsule filler has a dual dosing station, allowing combination capsule products to be manufactured, for example, tablets with powders, powders with beads, tablets with tablets, etc.
“The new technology is controlled by accurate computer systems, which, with expert design software, allow us to manage the development and scale-up and achieve improved speed of development and high yields for our customers.”
Penn Pharma, based in Tredegar in Blaenau Gwent, South Wales, delivers integrated drug development, clinical trial supply and manufacturing services to the international healthcare industry.
Penn Pharma Ltd, www.pennpharm.co.uk.